---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280730555.md"
description: "The Hong Kong innovative drug sector continued to rise in the afternoon, with JOINN and CSPC PHARMA up over 10%, INNOVENT BIO up over 7%, and JUNSHI BIO and INNOCARE following suit"
datetime: "2026-03-27T05:04:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280730555.md)
  - [en](https://longbridge.com/en/news/280730555.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280730555.md)
---

# 

The Hong Kong innovative drug sector continued to rise in the afternoon, with JOINN and CSPC PHARMA up over 10%, INNOVENT BIO up over 7%, and JUNSHI BIO and INNOCARE following suit.

### Related Stocks

- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [603127.CN](https://longbridge.com/en/quote/603127.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [06127.HK](https://longbridge.com/en/quote/06127.HK.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [688428.CN](https://longbridge.com/en/quote/688428.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [01877.HK](https://longbridge.com/en/quote/01877.HK.md)
- [517110.CN](https://longbridge.com/en/quote/517110.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [09969.HK](https://longbridge.com/en/quote/09969.HK.md)

## Related News & Research

- [InnoCare Pharma Seeks Approval for 2026 RMB Share Incentive Scheme and Wins HKEX Waiver](https://longbridge.com/en/news/284017056.md)
- [JOINN Laboratories Grants New Three-Year H-Share Awards to Management](https://longbridge.com/en/news/284780987.md)
- [CSPC Wins U.S. and China Trial Approvals for New Oncology Antibody-Drug Conjugate](https://longbridge.com/en/news/284559073.md)
- [CSPC Innovation Posts Strong Revenue Growth but Wider Losses in Q1 2026](https://longbridge.com/en/news/284213122.md)
- [Junshi Biosciences Board Approves 2026 Q1 Report at Fully Attended Meeting](https://longbridge.com/en/news/284233708.md)